+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Personalized Medicine Market Size, Share & Trends Analysis Report By Product (Personalized Medicine Therapeutics, Personalized Medical Care, Personalized Nutrition & Wellness), By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 180 Pages
  • May 2023
  • Region: Global
  • Grand View Research
  • ID: 4827925
Description Jump to:
The global personalized medicine market size is expected to reach USD 922.72 billion by 2030. The market is expected to register a CAGR of 7.20% from 2023 to 2030 owing to the increasing incidence of diseases and the rising demand for novel therapeutic drugs. The emerging applications of personalized medicine are consistently enhanced by immense research efforts. For instance, in July 2022, researchers at the UMass Chan Medical School developed a microorganism-based personalized medicine model system to aid the understanding of variation in metabolism to gauge the connection between an individual’s genome, diet, microbiota, and associative environmental factors.

Most cancer conditions are usually caused by an underlying genetic discrepancy and can cause fatalities with progression. The cancer condition can be effectively and precisely treated by understanding specific genomic characteristics. For instance, in May 2020, Qiagen launched QIAseq pan-cancer multi-modal panel to enable robust analysis of genomic characteristics of cancer subjects to derive a broad spectrum of applications in precision medicine for the profiling of solid tumors and heme malignancies.

The market is positively driven by advancements in NGS technologies and extensive research on the human genome. There has been an increasing focus on utilizing NGS to derive personalized medicine outcomes that could potentially be used for the treatment of cancer and rare genetic disorders. For instance, Illumina declared that it will present its multiple oncology research abstracts at the European Society of Medical Oncology (ESMO) annual meeting in Paris. Their research enables personalized cancer care using comprehensive genomic profiling of biopsies to match subjects to the potential drugs and immunotherapies.

Telemedicine facilitates virtual or telephonic clinical advice to aid physical convenience. Telemedicine is increasingly trending, especially after the COVID-19 pandemic. Government and research institutes are taking substantial efforts to enhance the applications of personalized telemedicine. For instance, in August 2022, the National Cancer Institute declared a grant of USD 23 million for five years to aid the launch of Telehealth Research Centers of Excellence (TRACE) across the U. S. The program was launched with the support of the White House Cancer Moonshot to seek development and advancements in telehealth delivery for cancer care with a mission to leverage health equity.

Molecular imaging systems and medical devices are playing a primary role in emerging advancements in personalized medicine. They effectively leverage the applications of personalized medicine in the treatment of different types of cancers. For instance, in June 2022, GE Healthcare declared the release of high-end molecular imaging by using gallium-68 radioisotope for the diagnosis and monitoring of prostate cancer so as to leverage access to precision health and theranostics for personalized prostate cancer treatment at an early stage of cancer progression.

The market is in the growth phase due to emerging technological advancements along with consistent industrial efforts such as collaborations and expansions. For instance, in December 2021, Biogen Inc., and TheraPanacea declared that they have signed a collaboration that focuses on advancing digital health for personalized medicine in neuroscience.

Personalized Medicine Market Report Highlights

  • The overall growth of the market is attributed to the rising need for novel therapeutic drugs coupled with leveraged genetic level understanding of diseases and the rising incidence of cancers and genetic disorders across the globe
  • The personalized medicine therapeutics segment is anticipated to witness high growth over the forecast period owing to the extensive usage of pharmacogenomics for developing biopharmaceuticals. Further, the genomic medicine therapeutics segment is anticipated to grow substantially during the forecast period owing to significantly lowered costs of whole-genome sequencing
  • North America dominated the market in 2022 due to the presence of key players and their intensive research for the development of novel therapies to find out curative solutions for various diseases


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Information Procurement
1.2. Information Or Data Analysis
1.3. Market Scope & Segment Definition
1.4. Market Model
1.4.1. Market Study, By Company Market Share
1.4.2. Regional Analysis
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Utility Of Human Genome Data For Clinical Research
3.2.1.1.1. Targeted And Personalized Healthcare
3.2.1.2. Technological Advancements To Facilitate R&D For Personalized Medicine
3.2.1.2.1. Emergence Of Advanced Genome Editing Techniques
3.2.1.2.2. Utility Of Novel Databases For Research
3.2.2. Market Restraint Analysis
3.2.2.1. Ethical Issues And Protection Of Individual’s Genomic Data
3.2.2.2. Limited Access To Human Genome Data And Databases
3.2.3. Market Opportunity Analysis
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Product Business Analysis
4.1. Personalized Medicine Market: Product Movement Analysis
4.2. Personalized Medicine Diagnostics
4.2.1. Personalized Medicine Diagnostics Market, 2018 - 2030 (USD Billion)
4.2.2. Genetic Testing
4.2.2.1. Genetic Testing Market, 2018 - 2030 (USD Billion)
4.2.3. Direct-To-Consumer (DTC) Diagnostics
4.2.3.1. Direct-To-Consumer (DTC) Diagnostics Market, 2018 - 2030 (USD Billion)
4.2.4. Esoteric Lab Services
4.2.4.1. Esoteric Lab Services Market, 2018 - 2030 (USD Billion)
4.2.5. Esoteric Lab Tests
4.2.5.1. Esoteric Lab Tests Market, 2018 - 2030 (USD Billion)
4.3. Personalized Medicine Therapeutics
4.3.1. Personalized Medicine Therapeutics Market, 2018 - 2030 (USD Billion)
4.3.2. Pharmaceutical
4.3.2.1. Pharamceutical Market, 2018 - 2030 (USD Billion)
4.3.3. Genomic Medicine
4.3.3.1. Genomic Medicine Market, 2018 - 2030 (USD Billion)
4.3.4. Medical Devices
4.3.4.1. Medical Devices Market, 2018 - 2030 (USD Billion)
4.4. Personalized Medical Care
4.4.1. Personlaized Medical Care Market, 2018 - 2030 (USD Billion)
4.4.2. Telemedicine
4.4.2.1. Telemedicine Market, 2018 - 2030 (USD Billion)
4.4.3. Health Information Technology
4.4.3.1. Health Inforamtion Technology Market, 2018 - 2030 (USD Billion)
4.5. Personalized Nutrition & Wellness
4.5.1. Personalzied Nutrtion & Wellness Market, 2018 - 2030 (USD Billion)
4.5.2. Retail Nutrition
4.5.2.1. Retail Nutrition Market, 2018 - 2030 (USD Billion)
4.5.3. Complementary & Alternative Medicine
4.5.3.1. Complementary & Alternative Medicine Market, 2018 - 2030 (USD Billion)
Chapter 5. Regional Business Analysis
5.1. Personalized Medicine Market Share By Region, 2022 & 2030
5.2. North America
5.2.1. SWOT Analysis
5.2.2. North America Personalized Medicine Market, 2018 - 2030 (USD Billion)
5.2.3. U.S.
5.2.3.1. Key Country Dynamics
5.2.3.2. Target Disease Prevalence
5.2.3.3. Competitive Scenario
5.2.3.4. Regulatory Framework
5.2.3.5. Reimbursement Scenario
5.2.3.6. U.S. Personalized Medicine Market, 2018 - 2030 (USD Billion)
5.2.4. Canada
5.2.4.1. Key Country Dynamics
5.2.4.2. Target Disease Prevalence
5.2.4.3. Competitive Scenario
5.2.4.4. Regulatory Framework
5.2.4.5. Reimbursement Scenario
5.2.4.6. Canada Personalized Medicine Market, 2018 - 2030 (USD Billion)
5.3. Europe
5.3.1. SWOT Analysis
5.3.2. Europe Personalized Medicine Market, 2018 - 2030 (USD Billion)
5.3.3. UK
5.3.3.1. Key Country Dynamics
5.3.3.2. Target Disease Prevalence
5.3.3.3. Competitive Scenario
5.3.3.4. Regulatory Framework
5.3.3.5. Reimbursement Scenario
5.3.3.6. UK Personalized Medicine Market, 2018 - 2030 (USD Billion)
5.3.4. Germany
5.3.4.1. Key Country Dynamics
5.3.4.2. Target Disease Prevalence
5.3.4.3. Competitive Scenario
5.3.4.4. Regulatory Framework
5.3.4.5. Reimbursement Scenario
5.3.4.6. Germany Personalized Medicine Market, 2018 - 2030 (USD Billion)
5.3.5. France
5.3.5.1. Key Country Dynamics
5.3.5.2. Target Disease Prevalence
5.3.5.3. Competitive Scenario
5.3.5.4. Regulatory Framework
5.3.5.5. Reimbursement Scenario
5.3.5.6. France Personalized Medicine Market, 2018 - 2030 (USD Billion)
5.3.6. Italy
5.3.6.1. Key Country Dynamics
5.3.6.2. Target Disease Prevalence
5.3.6.3. Competitive Scenario
5.3.6.4. Regulatory Framework
5.3.6.5. Reimbursement Scenario
5.3.6.6. Italy Personalized Medicine Market, 2018 - 2030 (USD Billion)
5.3.7. Spain
5.3.7.1. Key Country Dynamics
5.3.7.2. Target Disease Prevalence
5.3.7.3. Competitive Scenario
5.3.7.4. Regulatory Framework
5.3.7.5. Reimbursement Scenario
5.3.7.6. Spain Personalized Medicine Market, 2018 - 2030 (USD Billion)
5.3.8. Denmark
5.3.8.1. Key Country Dynamics
5.3.8.2. Target Disease Prevalence
5.3.8.3. Competitive Scenario
5.3.8.4. Regulatory Framework
5.3.8.5. Reimbursement Scenario
5.3.8.6. Denmark Personalized Medicine Market, 2018 - 2030 (USD Billion)
5.3.9. Sweden
5.3.9.1. Key Country Dynamics
5.3.9.2. Target Disease Prevalence
5.3.9.3. Competitive Scenario
5.3.9.4. Regulatory Framework
5.3.9.5. Reimbursement Scenario
5.3.9.6. Sweden Personalized Medicine Market, 2018 - 2030 (USD Billion)
5.3.10. Norway
5.3.10.1. Key Country Dynamics
5.3.10.2. Target Disease Prevalence
5.3.10.3. Competitive Scenario
5.3.10.4. Regulatory Framework
5.3.10.5. Reimbursement Scenario
5.3.10.6. Norway Personalized Medicine Market, 2018 - 2030 (USD Billion)
5.4. Asia Pacific
5.4.1. SWOT Analysis
5.4.2. Asia Pacific Personalized Medicine Market, 2018 - 2030 (USD Billion)
5.4.3. Japan
5.4.3.1. Key Country Dynamics
5.4.3.2. Target Disease Prevalence
5.4.3.3. Competitive Scenario
5.4.3.4. Regulatory Framework
5.4.3.5. Reimbursement Scenario
5.4.3.6. Japan Personalized Medicine Market, 2018 - 2030 (USD Billion)
5.4.4. China
5.4.4.1. Key Country Dynamics
5.4.4.2. Target Disease Prevalence
5.4.4.3. Competitive Scenario
5.4.4.4. Regulatory Framework
5.4.4.5. Reimbursement Scenario
5.4.4.6. China Personalized Medicine Market, 2018 - 2030 (USD Billion)
5.4.5. India
5.4.5.1. Key Country Dynamics
5.4.5.2. Target Disease Prevalence
5.4.5.3. Competitive Scenario
5.4.5.4. Regulatory Framework
5.4.5.5. Reimbursement Scenario
5.4.5.6. India Personalized Medicine Market, 2018 - 2030 (USD Billion)
5.4.6. Australia
5.4.6.1. Key Country Dynamics
5.4.6.2. Target Disease Prevalence
5.4.6.3. Competitive Scenario
5.4.6.4. Regulatory Framework
5.4.6.5. Reimbursement Scenario
5.4.6.6. Australia Personalized Medicine Market, 2018 - 2030 (USD Billion)
5.4.7. Thailand
5.4.7.1. Key Country Dynamics
5.4.7.2. Target Disease Prevalence
5.4.7.3. Competitive Scenario
5.4.7.4. Regulatory Framework
5.4.7.5. Reimbursement Scenario
5.4.7.6. Thailand Personalized Medicine Market, 2018 - 2030 (USD Billion)
5.4.8. South Korea
5.4.8.1. Key Country Dynamics
5.4.8.2. Target Disease Prevalence
5.4.8.3. Competitive Scenario
5.4.8.4. Regulatory Framework
5.4.8.5. Reimbursement Scenario
5.4.8.6. South Korea Personalized Medicine Market, 2018 - 2030 (USD Billion)
5.5. Latin America
5.5.1. SWOT Analysis
5.5.2. Latin America Personalized Medicine Market, 2018 - 2030 (USD Billion)
5.5.3. Brazil
5.5.3.1. Key Country Dynamics
5.5.3.2. Target Disease Prevalence
5.5.3.3. Competitive Scenario
5.5.3.4. Regulatory Framework
5.5.3.5. Reimbursement Scenario
5.5.3.6. Brazil Personalized Medicine Market, 2018 - 2030 (USD Billion)
5.5.4. Mexico
5.5.4.1. Key Country Dynamics
5.5.4.2. Target Disease Prevalence
5.5.4.3. Competitive Scenario
5.5.4.4. Regulatory Framework
5.5.4.5. Reimbursement Scenario
5.5.4.6. Mexico Personalized Medicine Market, 2018 - 2030 (USD Billion)
5.5.5. Argentina
5.5.5.1. Key Country Dynamics
5.5.5.2. Target Disease Prevalence
5.5.5.3. Competitive Scenario
5.5.5.4. Regulatory Framework
5.5.5.5. Reimbursement Scenario
5.5.5.6. Argentina Personalized Medicine Market, 2018 - 2030 (USD Billion)
5.6. MEA
5.6.1. SWOT Analysis
5.6.2. MEA Personalized Medicine Market, 2018 - 2030 (USD Billion)
5.6.3. South Africa
5.6.3.1. Key Country Dynamics
5.6.3.2. Target Disease Prevalence
5.6.3.3. Competitive Scenario
5.6.3.4. Regulatory Framework
5.6.3.5. Reimbursement Scenario
5.6.3.6. South Africa Personalized Medicine Market, 2018 - 2030 (USD Billion)
5.6.4. Saudi Arabia
5.6.4.1. Key Country Dynamics
5.6.4.2. Target Disease Prevalence
5.6.4.3. Competitive Scenario
5.6.4.4. Regulatory Framework
5.6.4.5. Reimbursement Scenario
5.6.4.6. Saudi Arabia Personalized Medicine Market, 2018 - 2030 (USD Billion)
5.6.5. UAE
5.6.5.1. Key Country Dynamics
5.6.5.2. Target Disease Prevalence
5.6.5.3. Competitive Scenario
5.6.5.4. Regulatory Framework
5.6.5.5. Reimbursement Scenario
5.6.5.6. UAE Personalized Medicine Market, 2018 - 2030 (USD Billion)
5.6.6. Kuwait
5.6.6.1. Key Country Dynamics
5.6.6.2. Target Disease Prevalence
5.6.6.3. Competitive Scenario
5.6.6.4. Regulatory Framework
5.6.6.5. Reimbursement Scenario
5.6.6.6. Kuwait Personalized Medicine Market, 2018 - 2030 (USD Billion)
Chapter 6. Competitive Landscape
6.1. Company Categorization
6.2. Strategy Mapping
6.3. Company Market Share Analysis, 2022
6.4. Company Profiles/Listing
6.4.1. GE Healthcare
6.4.1.1. Overview
6.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.1.3. Product Benchmarking
6.4.1.4. Strategic Initiatives
6.4.2. Illumina, Inc.
6.4.2.1. Overview
6.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.2.3. Product Benchmarking
6.4.2.4. Strategic Initiatives
6.4.3. ASURAGEN, INC.
6.4.3.1. Overview
6.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.3.3. Product Benchmarking
6.4.3.4. Strategic Initiatives
6.4.4. Abbott
6.4.4.1. Overview
6.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.4.3. Product Benchmarking
6.4.4.4. Strategic Initiatives
6.4.5. Dako A/S
6.4.5.1. Overview
6.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.5.3. Product Benchmarking
6.4.5.4. Strategic Initiatives
6.4.6. Exact Sciences Corporation
6.4.6.1. Overview
6.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.6.3. Product Benchmarking
6.4.6.4. Strategic Initiatives
6.4.7. Danaher Corporation (Cepheid, Inc.)
6.4.7.1. Overview
6.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.7.3. Product Benchmarking
6.4.7.4. Strategic Initiatives
6.4.8. Decode Genetics, Inc.
6.4.8.1. Overview
6.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.8.3. Product Benchmarking
6.4.8.4. Strategic Initiatives
6.4.9. QIAGEN
6.4.9.1. Overview
6.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.9.3. Product Benchmarking
6.4.9.4. Strategic Initiatives
6.4.10. Exagen Inc.
6.4.10.1. Overview
6.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.10.3. Product Benchmarking
6.4.10.4. Strategic Initiatives
6.4.11. Precision Biologics
6.4.11.1. Overview
6.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.11.3. Product Benchmarking
6.4.11.4. Strategic Initiatives
6.4.12. Celera Diagnostics LLC
6.4.12.1. Overview
6.4.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.12.3. Product Benchmarking
6.4.12.4. Strategic Initiatives
6.4.13. Biogen
6.4.13.1. Overview
6.4.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.13.3. Product Benchmarking
6.4.13.4. Strategic Initiatives
6.4.14. Genelex
6.4.14.1. Overview
6.4.14.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.14.3. Product Benchmarking
6.4.14.4. Strategic Initiatives
6.4.15. IBM
6.4.15.1. Overview
6.4.15.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.15.3. Product Benchmarking
6.4.15.4. Strategic Initiatives
6.4.16. Genentech, Inc.
6.4.16.1. Overview
6.4.16.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.16.3. Product Benchmarking
6.4.16.4. Strategic Initiatives
6.4.17. 23andMe, Inc.
6.4.17.1. Overview
6.4.17.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.17.3. Product Benchmarking
6.4.17.4. Strategic Initiatives
List of Tables
Table 1 List of abbreviations
Table 2 Global personalized medicine market, by region, 2018 - 2030 (USD Billion)
Table 3 Global personalized medicine market, by product, 2018 - 2030 (USD Billion)
Table 4 North America personalized medicine market, by country, 2018 - 2030 (USD Billion)
Table 5 North America personalized medicine market, by product, 2018 - 2030 (USD Billion)
Table 6 U.S. personalized medicine market, by product, 2018 - 2030 (USD Billion)
Table 7 Canada personalized medicine market, by product, 2018 - 2030 (USD Billion)
Table 8 Europe personalized medicine market, by country, 2018 - 2030 (USD Billion)
Table 9 Europe personalized medicine market, by product, 2018 - 2030 (USD Billion)
Table 10 Germany personalized medicine market, by product, 2018 - 2030 (USD Billion)
Table 11 UK personalized medicine market, by product, 2018 - 2030 (USD Billion)
Table 12 France personalized medicine market, by product, 2018 - 2030 (USD Billion)
Table 13 Italy personalized medicine market, by product, 2018 - 2030 (USD Billion)
Table 14 Spain personalized medicine market, by product, 2018 - 2030 (USD Billion)
Table 15 Denmark personalized medicine market, by product, 2018 - 2030 (USD Billion)
Table 16 Sweden personalized medicine market, by product, 2018 - 2030 (USD Billion)
Table 17 Norway personalized medicine market, by product, 2018 - 2030 (USD Billion)
Table 18 Asia Pacific personalized medicine market, by country, 2018 - 2030 (USD Billion)
Table 19 Asia Pacific personalized medicine market, by product, 2018 - 2030 (USD Billion)
Table 20 Japan personalized medicine market, by product, 2018 - 2030 (USD Billion)
Table 21 China personalized medicine market, by product, 2018 - 2030 (USD Billion)
Table 22 India personalized medicine market, by product, 2018 - 2030 (USD Billion)
Table 23 South Korea personalized medicine market, by product, 2018 - 2030 (USD Billion)
Table 24 Thailand personalized medicine market, by product, 2018 - 2030 (USD Billion)
Table 25 Australia personalized medicine market, by product, 2018 - 2030 (USD Billion)
Table 26 Latin America personalized medicine market, by country, 2018 - 2030 (USD Billion)
Table 27 Latin America personalized medicine market, by product, 2018 - 2030 (USD Billion)
Table 28 Brazil personalized medicine market, by product, 2018 - 2030 (USD Billion)
Table 29 Mexico personalized medicine market, by product, 2018 - 2030 (USD Billion)
Table 30 Argentina personalized medicine market, by product, 2018 - 2030 (USD Billion)
Table 31 MEA personalized medicine market, by country, 2018 - 2030 (USD Billion)
Table 32 MEA personalized medicine market, by product, 2018 - 2030 (USD Billion)
Table 33 South Africa personalized medicine market, by product, 2018 - 2030 (USD Billion)
Table 34 Saudi Arabia personalized medicine market, by product, 2018 - 2030 (USD Billion)
Table 35 UAE personalized medicine market, by product, 2018 - 2030 (USD Billion)
Table 36 Kuwait personalized medicine market, by product, 2018 - 2030 (USD Billion)
List of Figures
Fig. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain-based sizing & forecasting
FIG. 6 Market formulation & validation
FIG. 7 Personalized medicine market segmentation
FIG. 8 Market snapshot, 2022
FIG. 9 Market trends & outlook
FIG. 10 Market driver relevance analysis (current & future impact)
FIG. 11 Market restraint relevance analysis (current & future impact)
FIG. 12 PESTEL analysis
FIG. 13 Porter’s five forces analysis
FIG. 14 Global personalized medicine market, for product, 2018 - 2030 (USD Billion)
FIG. 15 Global personalized medicine market, for diagnostics, 2018 - 2030 (USD Billion)
FIG. 16 Global personalized medicine market, for genetic testing, 2018 - 2030 (USD Billion)
FIG. 17 Global personalized medicine market, for Direct-To-Consumer (DTC) testing, 2018 - 2030 (USD Billion)
FIG. 18 Global personalized medicine market, for esoteric lab services, 2018 - 2030 (USD Billion)
FIG. 19 Global personalized medicine market, for esoteric lab tests, 2018 - 2030 (USD Billion)
FIG. 20 Global personalized medicine market, for therapeutics, 2018 - 2030 (USD Billion)
FIG. 21 Global personalized medicine market, for pharmaceutical, 2018 - 2030 (USD Billion)
FIG. 22 Global personalized medicine market, for genomic medicine, 2018 - 2030 (USD Billion)
FIG. 23 Global personalized medicine market, for medical devices, 2018 - 2030 (USD Billion)
FIG. 24 Global personalized medicine market, for personalized medical care, 2018 - 2030 (USD Billion)
FIG. 25 Global personalized medicine market, for telemedicine, 2018 - 2030 (USD Billion)
FIG. 26 Global personalized medicine market, for health information technology, 2018 - 2030 (USD Billion)
FIG. 27 Global personalized medicine market, for personalized nutrition & wellness, 2018 - 2030 (USD Billion)
FIG. 28 Global personalized medicine market, for retail nutrition, 2018 - 2030 (USD Billion)
FIG. 29 Global personalized medicine market, for complementary & alternative medicine, 2018 - 2030 (USD Billion)
FIG. 30 Regional outlook, 2022 & 2030
FIG. 31 North America personalized medicine market, 2018 - 2030 (USD Billion)
FIG. 32 U.S. personalized medicine market, 2018 - 2030 (USD Billion)
FIG. 33 Canada personalized medicine market, 2018 - 2030 (USD Billion)
FIG. 34 Europe personalized medicine market, 2018 - 2030 (USD Billion)
FIG. 35 Germany personalized medicine market, 2018 - 2030 (USD Billion)
FIG. 36 UK personalized medicine market, 2018 - 2030 (USD Billion)
FIG. 37 France personalized medicine market, 2018 - 2030 (USD Billion)
FIG. 38 Italy personalized medicine market, 2018 - 2030 (USD Billion)
FIG. 39 Spain personalized medicine market, 2018 - 2030 (USD Billion)
FIG. 40 Denmark personalized medicine market, 2018 - 2030 (USD Billion)
FIG. 41 Sweden personalized medicine market, 2018 - 2030 (USD Billion)
FIG. 42 Norway personalized medicine market, 2018 - 2030 (USD Billion)
FIG. 43 Asia Pacific personalized medicine market, 2018 - 2030 (USD Billion)
FIG. 44 Japan personalized medicine market, 2018 - 2030 (USD Billion)
FIG. 45 China personalized medicine market, 2018 - 2030 (USD Billion)
FIG. 46 India personalized medicine market, 2018 - 2030 (USD Billion)
FIG. 47 Australia personalized medicine market, 2018 - 2030 (USD Billion)
FIG. 48 Thailand personalized medicine market, 2018 - 2030 (USD Billion)
FIG. 49 South Korea personalized medicine market, 2018 - 2030 (USD Billion)
FIG. 50 Latin America personalized medicine market, 2018 - 2030 (USD Billion)
FIG. 51 Brazil personalized medicine market, 2018 - 2030 (USD Billion)
FIG. 52 Mexico personalized medicine market, 2018 - 2030 (USD Billion)
FIG. 53 Argentina personalized medicine market, 2018 - 2030 (USD Billion)
FIG. 54 MEA personalized medicine market, 2018 - 2030 (USD Billion)
FIG. 55 South Africa personalized medicine market, 2018 - 2030 (USD Billion)
FIG. 56 Saudi Arabia personalized medicine market, 2018 - 2030 (USD Billion)
FIG. 57 UAE personalized medicine market, 2018 - 2030 (USD Billion)
FIG. 58 Kuwait personalized medicine market, 2018 - 2030 (USD Billion)

Companies Mentioned

  • GE Healthcare
  • Illumina, Inc.
  • ASURAGEN, INC.
  • Abbott
  • Dako A/S
  • Exact Sciences Corporation
  • Danaher Corporation (Cepheid, Inc.)
  • Decode Genetics, Inc.
  • QIAGEN
  • Exagen Inc.
  • Precision Biologics
  • Celera Diagnostics LLC
  • Biogen
  • Genelex
  • IBM
  • Genentech, Inc.
  • 23andMe, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages180
PublishedMay 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 538.93 Billion
Forecasted Market Value ( USD ) by 2030 $ 922.72 Billion
Compound Annual Growth Rate7.2%
Regions CoveredGlobal
No. of Companies Mentioned17

Related Topics

Related Reports

Molecular Cytogenetics Market Size, Share & Trends Analysis Report By Application (Oncology, Personalized Medicine), By Technology (FISH, Immunohistochemistry, Karyotyping), By Product, By End-use, By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Molecular Cytogenetics Market Size, Share & Trends Analysis Report By Application (Oncology, Personalized Medicine), By Technology (FISH, Immunohistochemistry, Karyotyping), By Product, By End-use, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 236 Pages
  • Global
From
Nanomaterials in Personalized Medicine: Global Markets - Product Image

Nanomaterials in Personalized Medicine: Global Markets

  • Report
  • 226 Pages
  • Global
From
Personalized Medicine Global Market Report 2024 - Product Image

Personalized Medicine Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Personalized Medicines: Global Strategic Business Report - Product Image

Personalized Medicines: Global Strategic Business Report

  • Report
  • 216 Pages
  • Global
From
Generative AI in Personalized Medicine Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Generative AI in Personalized Medicine Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From

About the Personalized Medicine Market

Personalized Medicine is a form of biotechnology that focuses on tailoring medical treatments to the individual needs of a patient. It is based on the idea that each person's genetic makeup, lifestyle, and environment can affect their response to a particular treatment. This approach to medicine has the potential to improve patient outcomes and reduce healthcare costs. Personalized Medicine utilizes a variety of technologies, such as genomics, proteomics, and metabolomics, to identify and analyze a patient's unique characteristics. This information is then used to develop treatments that are tailored to the individual's needs. Additionally, personalized medicine can be used to identify and monitor diseases, predict drug responses, and develop new treatments. Some companies in the Personalized Medicine market include 23andMe, Illumina, and Thermo Fisher Scientific. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.